HKSE · 3692.HK
Hansoh Pharmaceutical Group Company Limited
HK$32.50-HK$0.58 (-1.75%)
Hansoh Pharmaceutical Group Company Limited’s quoted price sits in the lower half of its reported 52-week range, 26.41% below the high.
Loading market information…
HKSE · 2633.HK · HKD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:26 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
Jacobson Pharma Corporation Limited’s quoted price sits in the lower half of its reported 52-week range, 36.58% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Jacobson Pharma Corporation Limited’s forward annual dividend is HK$0.07 per share, paid semi-annual. The forward yield is 7.41% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Jacobson Pharma Corporation Limited’s next earnings report is currently expected on Nov 20, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Jacobson Pharma Corporation Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Jacobson Pharma Corporation Limited, a subsidiary of Kingshill Development Limited, specializes in the production, promotion, and distribution of generic medications and branded healthcare products. Its market reach extends across Hong Kong, mainland China, Macau, Singapore, and international territories. The company offers a broad selection of generic pharmaceuticals targeting diverse medical conditions, including respiratory, cardiovascular, central nervous system, gastrointestinal, genito-urinary, musculoskeletal, endocrine and metabolic, dermatological, anti-allergic, scar treatment, oral anti-diabetic, and anti-infective categories. Specific examples comprise arsenic trioxide oral solutions, rosuvastatin tablets, and atorvastatin tablets. In addition to generics, the company provides branded medications, health and wellness products, and traditional Chinese remedies. Prominent proprietary Chinese medicines include Po Chai pills, Ho Chai Kung Tji Thung San, Tong Tai Chung Woodlok oil, Flying Eagle Woodlok Oil, Saplingtan, Shiling oil, Contractubex, Doan's Ointment, and Col-gan tablets. Its operations also extend to trading medical provisions, procuring packaging materials, distributing herbal and health-related goods, conducting research and development, and managing property holdings. The company distributes its offerings to a wide range of clients, including hospitals, clinics, authorized pharmacies, independent physicians, retail outlets, and trading companies. Founded in 2016, Jacobson Pharma Corporation Limited is headquartered in Kwun Tong, Hong Kong.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:13 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$32.50-HK$0.58 (-1.75%)
Hansoh Pharmaceutical Group Company Limited’s quoted price sits in the lower half of its reported 52-week range, 26.41% below the high.
HK$6.84-HK$0.02 (-0.22%)
The United Laboratories International Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 50.15% below the high.
HK$1.60+HK$0.03 (+1.59%)
Luye Pharma Group Ltd.’s quoted price sits in the lower half of its reported 52-week range, 51.22% below the high.
HK$5.45-HK$0.18 (-3.2%)
CF PharmTech, Inc.’s quoted price sits in the lower half of its reported 52-week range, 86.2% below the high.
HK$0.92-HK$0.02 (-2.14%)
Dawnrays Pharmaceutical (Holdings) Limited’s quoted price sits in the lower half of its reported 52-week range, 26.8% below the high.
HK$1.65+HK$0.04 (+2.48%)
JBM (Healthcare) Limited’s quoted price sits in the lower half of its reported 52-week range, 46.95% below the high.
HK$2.02HK$0.00 (0.0%)
Essex Bio-Technology Limited’s quoted price sits in the lower half of its reported 52-week range, 56.57% below the high.
HK$0.98-HK$0.02 (-2.0%)
Fusen Pharmaceutical Company Limited’s quoted price sits in the lower half of its reported 52-week range, 31.94% below the high.
